Bio-Physical Sovereignty and the Tri-Tier Pharmacological Architecture of Human Milk: Deterministic Multi-Path Error Correction via HAMLET/Alpha1H, Blood-Brain Barrier Homing of hBSCs, Glycan-Mediated Gut-Brain Modulation by HMOs, and QFS-zkVM Intellectual Property Fortification

Conventional biomedical paradigms classify human breast milk primarily as a passive nutritional substrate supplemented by maternal immunoglobulins. This monograph refutes that reductionist view, proving that human milk operates as an evolutionarily engineered, tri-tier deterministic bio-information transmission and physical-layer error-correction protocol. First, we formalize HAMLET (Human alpha-Lactalbumin Made Lethal to Tumor Cells) and its synthetic peptide-oleate analogue Alpha1H as a pH-gated thermodynamic state machine. Triggered by the low-pH gastric microenvironment (pH <= 4.5), alpha-lactalbumin releases Ca2+ and co-assembles with oleic acid to execute a simultaneous four-channel intracellular clamp across the 20S proteasome, endoplasmic reticulum (ER)/macroautophagy flux, mitochondrial membranes, and histone H3/H4 chromatin architecture. We prove mathematically that this orthogonal multi-path clamp is structurally isomorphic to a deterministic hardware interlock (RTO P2.0), bypassing canonical oncogenic resistance states including complete p53 deletion, Bcl-2 overexpression, and caspase inhibition, as validated in Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) trials demonstrating an 82% high-dose clinical response and downregulation of over 700 oncogenic gene networks. Second, we formulate a coupled system of partial differential equations (PDEs) uniting Human Breast Milk Stem Cells (hBSCs)—which express core pluripotency transcription factors (OCT4, SOX2, NANOG) without teratoma risk, survive gastric proteolysis, traverse the intestinal epithelium and Blood-Brain Barrier (BBB), and home to ischemic peri-infarct penumbra—with over 200 Human Milk Oligosaccharides (HMOs), specifically 2'-fucosyllactose (2'-FL) and 6'-sialyllactose (6'-SL). We model how 2'-FL and 6'-SL selectively fuel Bifidobacterium longum subsp. infantis, inhibit chemokine release (IL-8, CCL20) via direct PPAR-gamma activation, and modulate the Microbiota-Gut-Brain Axis (MGBA) to accelerate microglial clearance of amyloid-beta (Abeta1-42) and hyperphosphorylated Tau (p-Tau). Finally, to prevent algorithmic biopiracy and unauthorized foundation-model scraping of multi-omic patient cohorts and glycan-stem-cell protocols, we embed the entire bio-pharmacological dataset within a Quantum Financial System Zero-Knowledge Virtual Machine (QFS-zkVM) Pay-to-Decrypt architecture over the 64-bit Goldilocks prime field Fp (p = 2^64 - 2^32 + 1) governed by Human-in-Command (HIC) statutory covenants and the Strict No-Learn Covenant (NLL-v1.0-2026).